首页 > 最新文献

Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan最新文献

英文 中文
Challenges and strategies of Thailand's personal data protection act in Traditional Chinese Medicine clinical research. 泰国中医临床研究个人资料保护法面临的挑战与对策
Pub Date : 2025-12-01 DOI: 10.19852/j.cnki.jtcm.2025.06.021
Wan Gengxin, Zhao Ye, Zhang Meihong
{"title":"Challenges and strategies of Thailand's personal data protection act in Traditional Chinese Medicine clinical research.","authors":"Wan Gengxin, Zhao Ye, Zhang Meihong","doi":"10.19852/j.cnki.jtcm.2025.06.021","DOIUrl":"10.19852/j.cnki.jtcm.2025.06.021","url":null,"abstract":"","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"45 6","pages":"1435-1436"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12703692/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145727516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dongtian Changchun ointment for moderate-to-severe chronic obstructive pulmonary disease: a multicenter, prospective, open-label, randomized controlled trial. 冬天长春软膏治疗中重度慢性阻塞性肺疾病:一项多中心、前瞻性、开放标签、随机对照试验
Pub Date : 2025-12-01 DOI: 10.19852/j.cnki.jtcm.2025.06.017
Zhang Yibao, Chen Feng, Sun Meng, Wang Zhenwei, Tang Binqing, Qian Yechang, Jia Wei, Bao Yufang, L I Wenjie, L I Shanqun, Zhang Wei

Objective: To evaluate the clinical efficacy and safety of Dongtian Changchun ointment (, DTCO) for the treatment of patients with stable moderate-to-severe chronic obstructive pulmonary disease (COPD).

Methods: This was a multicenter, prospective, open-label, randomized controlled trial. Patients with COPD who met the inclusion and exclusion criteria were randomly divided into a DTCO group and a control group in a 1∶1 ratio. Both groups were treated with Symbicort Turbuhaler (320 μg / 9 μg twice daily) for 48 weeks. The DTCO group was given additional DTCO (15 g twice daily) for the first 12 weeks. Outcome assessments were conducted at five time points: 0, 12, 24, 36, and 48 weeks. Primary outcome measures included frequency and duration of acute exacerbation of COPD (AECOPD). Secondary outcomes included St. George's Breathing Questionnaire, pulmonary function, 6-min walk test, and modified Medical Research Council (mMRC) scores.

Results: A total of 84 patients were randomly divided into the DTCO group (n = 42) and the control group (n = 42). The results showed that in the DTCO group, 23 patients had AECOPD for a total duration of 166 d compared with 31 patients in the control group for a total duration of 307 d. Compared with the control group, the DTCO group showed a significant reduction in the median (interquartile range) frequency and duration of AECOPD (P < 0.05). The incidence of AECOPD significantly reduced in the DTCO group to 0.539 [95% confidence interval (0.347, 0.836), P = 0.006]. In the DTCO group, a significant improvement in forced vital capacity was observed at 12 and 48 weeks (P < 0.05), and a reduction in mMRC was noted at 36 and 48 weeks (P < 0.05). There was no significant difference in the incidence of adverse events between the two groups.

Conclusions: DTCO significantly reduced the frequency and duration of AECOPD in patients with moderate-to-severe COPD, and demonstrated satisfactory safety.

目的:评价冬天长春软膏(DTCO)治疗稳定期中重度慢性阻塞性肺疾病(COPD)患者的临床疗效和安全性。方法:这是一项多中心、前瞻性、开放标签、随机对照试验。将符合纳入和排除标准的COPD患者按1∶1的比例随机分为DTCO组和对照组。两组患者均给予辛比柯尔(320 μg / 9 μg,每日2次)治疗,疗程48周。DTCO组在前12周给予额外的DTCO (15 g,每日两次)。结果评估在5个时间点进行:0、12、24、36和48周。主要结局指标包括慢性阻塞性肺病(AECOPD)急性加重的频率和持续时间。次要结果包括圣乔治呼吸问卷、肺功能、6分钟步行测试和修改后的医学研究委员会(mMRC)评分。结果:84例患者随机分为DTCO组(n = 42)和对照组(n = 42)。结果显示,DTCO组有23例患者发生AECOPD,总持续时间为166 d,而对照组有31例患者发生AECOPD,总持续时间为307 d。与对照组相比,DTCO组AECOPD发生频率中位数(四分位间距)和持续时间均显著降低(P < 0.05)。DTCO组AECOPD发生率显著降低至0.539[95%可信区间(0.347,0.836),P = 0.006]。DTCO组在12周和48周时用力肺活量显著改善(P < 0.05), 36周和48周时mMRC显著降低(P < 0.05)。两组患者不良事件发生率无显著差异。结论:DTCO可显著降低中重度COPD患者AECOPD的发生频率和持续时间,且安全性令人满意。
{"title":"Dongtian Changchun ointment for moderate-to-severe chronic obstructive pulmonary disease: a multicenter, prospective, open-label, randomized controlled trial.","authors":"Zhang Yibao, Chen Feng, Sun Meng, Wang Zhenwei, Tang Binqing, Qian Yechang, Jia Wei, Bao Yufang, L I Wenjie, L I Shanqun, Zhang Wei","doi":"10.19852/j.cnki.jtcm.2025.06.017","DOIUrl":"10.19852/j.cnki.jtcm.2025.06.017","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the clinical efficacy and safety of Dongtian Changchun ointment (, DTCO) for the treatment of patients with stable moderate-to-severe chronic obstructive pulmonary disease (COPD).</p><p><strong>Methods: </strong>This was a multicenter, prospective, open-label, randomized controlled trial. Patients with COPD who met the inclusion and exclusion criteria were randomly divided into a DTCO group and a control group in a 1∶1 ratio. Both groups were treated with Symbicort Turbuhaler (320 μg / 9 μg twice daily) for 48 weeks. The DTCO group was given additional DTCO (15 g twice daily) for the first 12 weeks. Outcome assessments were conducted at five time points: 0, 12, 24, 36, and 48 weeks. Primary outcome measures included frequency and duration of acute exacerbation of COPD (AECOPD). Secondary outcomes included St. George's Breathing Questionnaire, pulmonary function, 6-min walk test, and modified Medical Research Council (mMRC) scores.</p><p><strong>Results: </strong>A total of 84 patients were randomly divided into the DTCO group (<i>n =</i> 42) and the control group (<i>n =</i> 42). The results showed that in the DTCO group, 23 patients had AECOPD for a total duration of 166 d compared with 31 patients in the control group for a total duration of 307 d. Compared with the control group, the DTCO group showed a significant reduction in the median (interquartile range) frequency and duration of AECOPD (<i>P <</i> 0.05). The incidence of AECOPD significantly reduced in the DTCO group to 0.539 [95% confidence interval (0.347, 0.836), <i>P =</i> 0.006]. In the DTCO group, a significant improvement in forced vital capacity was observed at 12 and 48 weeks (<i>P <</i> 0.05), and a reduction in mMRC was noted at 36 and 48 weeks (<i>P <</i> 0.05). There was no significant difference in the incidence of adverse events between the two groups.</p><p><strong>Conclusions: </strong>DTCO significantly reduced the frequency and duration of AECOPD in patients with moderate-to-severe COPD, and demonstrated satisfactory safety.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"45 6","pages":"1395-1404"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12712291/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145727770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Xuanfei Tongqiao acupuncture on nasal inflammation in rats with allergic rhinitis: modulation of long non-coding RNA growth arrest-specific transcript 5 methylation modification. 宣肺通窍针对变应性鼻炎大鼠鼻腔炎症的影响:长链非编码RNA生长阻滞特异性转录物5甲基化修饰的调节。
Pub Date : 2025-12-01 DOI: 10.19852/j.cnki.jtcm.2025.06.007
Lyu Hequn, Zeng Chunli, Zhang Hanrui, Yang Chen, Shen Yan, Peng Yongjun

Objective: To examine the effect of Xuanfei Tongqiao acupuncture on nasal inflammation in rats with allergic rhinitis (AR) and its underlying mechanisms, particularly focusing on the role of acupuncture in regulating the methylation of long non-coding RNA growth arrest-specific transcript 5 (lncRNA GAS5).

Methods: Interventions involved acupuncture or short hairpin RNA-GAS5 (sh-GAS5) lentivirus in an ovalbumin-induced AR rat model. Nasal mucosal tissues were collected post-intervention for pathological analysis. Parameters assessed included the proportion of type 2 innate lymphoid cells (ILC2s), the expression of GATA binding protein 3 (GATA3), methyltransferase-like 3 (METTL3), interleukin (IL)-33 proteins, and the expression of METTL3 and lncRNA-GAS5.

Results: Xuanfei Tongqiao acupuncture and/or lentivirus sh-GAS5 significantly alleviated rhinitis symptoms and reduced nasal inflammation in AR rats. This was evidenced by a reduction in inflammatory cells, eosinophils, and cuprocytes in nasal mucosal tissues, along with a decreased proportion of ILC2s. Furthermore, protein levels of GATA3, METTL3, and IL-33, as well as the expression of METTL3 and lncRNA-GAS5, were significantly reduced. These findings suggest that lncRNA-GAS5 and its N6-methyladenosine methylation are key regulators of AR inflammation, with acupuncture exerting a modulatory effect on this pathway.

Conclusions: Xuanfei Tongqiao acupuncture therapy inhibited the METTL3-GAS5-GATA3-IL-33-ILC2 pathway, reducing the inflammatory response and alleviating nasal symptoms in AR rats. These results suggest that Xuanfei Tongqiao acupuncture could serve as a potential alternative therapy for preventing and managing AR associated with inflammation.

目的:探讨宣肺通窍针对变应性鼻炎(AR)大鼠鼻部炎症的影响及其机制,重点研究针刺在调节长链非编码RNA生长阻滞特异性转录本5 (lncRNA GAS5)甲基化中的作用。方法:采用针刺或短发夹RNA-GAS5 (sh-GAS5)慢病毒对卵清蛋白诱导的AR大鼠模型进行干预。术后收集鼻黏膜组织进行病理分析。评估的参数包括2型先天淋巴样细胞(ILC2s)比例、GATA结合蛋白3 (GATA3)、甲基转移酶样3 (METTL3)、白细胞介素(IL)-33蛋白的表达、METTL3和lncRNA-GAS5的表达。结果:宣肺通窍针刺和/或慢病毒sh-GAS5可显著缓解AR大鼠鼻炎症状,减轻鼻部炎症反应。这可以通过鼻黏膜组织中炎症细胞、嗜酸性粒细胞和铜原细胞的减少以及ILC2s比例的降低来证明。此外,GATA3、METTL3和IL-33蛋白水平以及METTL3和lncRNA-GAS5的表达均显著降低。这些发现表明lncRNA-GAS5及其n6 -甲基腺苷甲基化是AR炎症的关键调节因子,针刺对这一途径具有调节作用。结论:宣肺通窍针刺疗法可抑制急性鼻炎大鼠METTL3-GAS5-GATA3-IL-33-ILC2通路,降低炎症反应,缓解鼻部症状。这些结果表明,宣肺通桥针刺可以作为预防和治疗与炎症相关的AR的潜在替代疗法。
{"title":"Effect of Xuanfei Tongqiao acupuncture on nasal inflammation in rats with allergic rhinitis: modulation of long non-coding RNA growth arrest-specific transcript 5 methylation modification.","authors":"Lyu Hequn, Zeng Chunli, Zhang Hanrui, Yang Chen, Shen Yan, Peng Yongjun","doi":"10.19852/j.cnki.jtcm.2025.06.007","DOIUrl":"10.19852/j.cnki.jtcm.2025.06.007","url":null,"abstract":"<p><strong>Objective: </strong>To examine the effect of Xuanfei Tongqiao acupuncture on nasal inflammation in rats with allergic rhinitis (AR) and its underlying mechanisms, particularly focusing on the role of acupuncture in regulating the methylation of long non-coding RNA growth arrest-specific transcript 5 (lncRNA GAS5).</p><p><strong>Methods: </strong>Interventions involved acupuncture or short hairpin RNA-GAS5 (sh-GAS5) lentivirus in an ovalbumin-induced AR rat model. Nasal mucosal tissues were collected post-intervention for pathological analysis. Parameters assessed included the proportion of type 2 innate lymphoid cells (ILC2s), the expression of GATA binding protein 3 (GATA3), methyltransferase-like 3 (METTL3), interleukin (IL)-33 proteins, and the expression of METTL3 and lncRNA-GAS5.</p><p><strong>Results: </strong>Xuanfei Tongqiao acupuncture and/or lentivirus sh-GAS5 significantly alleviated rhinitis symptoms and reduced nasal inflammation in AR rats. This was evidenced by a reduction in inflammatory cells, eosinophils, and cuprocytes in nasal mucosal tissues, along with a decreased proportion of ILC2s. Furthermore, protein levels of GATA3, METTL3, and IL-33, as well as the expression of METTL3 and lncRNA-GAS5, were significantly reduced. These findings suggest that lncRNA-GAS5 and its N6-methyladenosine methylation are key regulators of AR inflammation, with acupuncture exerting a modulatory effect on this pathway.</p><p><strong>Conclusions: </strong>Xuanfei Tongqiao acupuncture therapy inhibited the METTL3-GAS5-GATA3-IL-33-ILC2 pathway, reducing the inflammatory response and alleviating nasal symptoms in AR rats. These results suggest that Xuanfei Tongqiao acupuncture could serve as a potential alternative therapy for preventing and managing AR associated with inflammation.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"45 6","pages":"1263-1272"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12711635/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145727817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Key elements for screening kidney deficiency pattern in Traditional Chinese and Korean Medicine: a systematic review and Delphi study. 中朝医学肾虚证筛选要点:系统回顾与德尔菲研究。
Pub Date : 2025-12-01 DOI: 10.19852/j.cnki.jtcm.2025.06.001
Hyungsun Jun, Nahyun Cho, Wonbae Ha, Junghan Lee, Mi Mi Ko, Young-Eun Kim, Jeeyoun Jung, Jungtae Leem

Objective: To identify key elements for screening kidney deficiency pattern (KDP) through a systematic review and Delphi methodology to detect high-risk KDP groups.

Methods: We first conducted a systematic review to extract kidney system patterns and then performed four rounds of the Delphi. After the third round, two face-to-face consensus meetings were held to finalize the consensus. The English version of the KDP Screening Questionnaire (KDPScreenQ) was developed through agreement between a bilingual physician and the research team.

Results: A systematic review identified 35 studies that predominantly focused on KDP, KDP-Yin, and KDP-Yang. Twenty-two common symptoms were reported in five or more studies. A panel of ten experts, including specialists in internal medicine and diagnostics, participated in all four rounds of the Delphi process. The final KDPScreenQ comprises 20 key elements. Key elements for KDP include lassitude; weakness, and pain in the lumbar region and knee joints (four items); reduced libido or sexual dysfunction; tinnitus or deafness; urinary incontinence (two items); thinning and loss of hair; forgetfulness; loose teeth and weak gums. Key elements for KDP-Yin include heat sensation in the palms and feet; a sensation of heat and tightness in the chest (particularly in the afternoon); night sweats; and dry mouth. Key elements for KDP-Yang include aversion to cold; edema; early morning diarrhea; and loose stools.

Conclusion: The KDPScreenQ is a fundamental tool for standardizing KDP differentiation, serving both to screen patients with KDP and to track their long-term prognosis. This questionnaire will next be used in a prospective observational study to determine cut-off values.

目的:通过系统评价和德尔菲法寻找肾虚证(KDP)高危人群的关键因素。方法:我们首先进行系统综述,提取肾系统模式,然后进行四轮德尔菲。第三轮谈判结束后,双方举行了两次面对面协商会议,最终达成共识。英文版的KDP筛查问卷(KDPScreenQ)是由一位双语医师和研究团队共同制定的。结果:一项系统综述确定了35项研究,主要集中在KDP, KDP-阴和KDP-阳。在五项或更多的研究中报告了22种常见症状。一个由10名专家组成的小组,包括内科和诊断专家,参加了所有四轮德尔菲过程。最终的KDPScreenQ包含20个关键元素。KDP的关键要素包括疲劳;腰、膝关节无力、疼痛(四项);性欲减退或性功能障碍;耳鸣或耳聋;尿失禁(两项);脱发:头发稀疏或脱落;健忘的;牙齿松动,牙龈虚弱。kdp阴的关键要素包括手掌和脚的热感觉;胸闷,胸闷:胸部发热和闷闷的感觉(特别是在下午);盗汗;还有口干。KDP-Yang的关键要素包括厌恶寒冷;水肿;清晨腹泻;和稀便。结论:KDPScreenQ是标准化KDP鉴别的基本工具,既可筛查KDP患者,又可跟踪其长期预后。该问卷接下来将用于前瞻性观察研究,以确定临界值。
{"title":"Key elements for screening kidney deficiency pattern in Traditional Chinese and Korean Medicine: a systematic review and Delphi study.","authors":"Hyungsun Jun, Nahyun Cho, Wonbae Ha, Junghan Lee, Mi Mi Ko, Young-Eun Kim, Jeeyoun Jung, Jungtae Leem","doi":"10.19852/j.cnki.jtcm.2025.06.001","DOIUrl":"10.19852/j.cnki.jtcm.2025.06.001","url":null,"abstract":"<p><strong>Objective: </strong>To identify key elements for screening kidney deficiency pattern (KDP) through a systematic review and Delphi methodology to detect high-risk KDP groups.</p><p><strong>Methods: </strong>We first conducted a systematic review to extract kidney system patterns and then performed four rounds of the Delphi. After the third round, two face-to-face consensus meetings were held to finalize the consensus. The English version of the KDP Screening Questionnaire (KDPScreenQ) was developed through agreement between a bilingual physician and the research team.</p><p><strong>Results: </strong>A systematic review identified 35 studies that predominantly focused on KDP, KDP-<i>Yin</i>, and KDP-<i>Yang</i>. Twenty-two common symptoms were reported in five or more studies. A panel of ten experts, including specialists in internal medicine and diagnostics, participated in all four rounds of the Delphi process. The final KDPScreenQ comprises 20 key elements. Key elements for KDP include lassitude; weakness, and pain in the lumbar region and knee joints (four items); reduced libido or sexual dysfunction; tinnitus or deafness; urinary incontinence (two items); thinning and loss of hair; forgetfulness; loose teeth and weak gums. Key elements for KDP-<i>Yin</i> include heat sensation in the palms and feet; a sensation of heat and tightness in the chest (particularly in the afternoon); night sweats; and dry mouth. Key elements for KDP-<i>Yang</i> include aversion to cold; edema; early morning diarrhea; and loose stools.</p><p><strong>Conclusion: </strong>The KDPScreenQ is a fundamental tool for standardizing KDP differentiation, serving both to screen patients with KDP and to track their long-term prognosis. This questionnaire will next be used in a prospective observational study to determine cut-off values.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"45 6","pages":"1169-1177"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12711456/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145727834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psoriasis intervention by Huai'er (): unveiling novel targetsnetwork pharmacology. 怀尔干预银屑病:揭示新靶点网络药理学。
Pub Date : 2025-12-01 DOI: 10.19852/j.cnki.jtcm.2025.06.011
L I Keyao, Shu Ye, Chang Jing, Tang Jianping, Zhang Litao, Wei Zhu

Objective: To investigate the therapeutic effects of Huai'er (Trametes) on psoriasis by identifying specific molecular targets and pathways involved in regulating keratinocyte behavior and immune responses.

Methods: Cellular experiments were conducted using human keratinocyte cell line (HaCaT) keratinocytes to evaluate the effects of Huai'er (Trametes) on cell proliferation, migration, and inflammatory factor expression. Additionally, an imiquimod (IMQ)-induced psoriasis-like mouse model was established to assess the therapeutic efficacy of Huai'er (Trametes) in vivo. Network pharmacology and transcriptomic analyses were performed to identify potential targets and pathways.

Results: Huai'er (Trametes) significantly inhibited HaCaT keratinocyte proliferation and migration in vitro, as evidenced by reduced 5-ethynyl-2'-deoxyuridine incorporation and wound healing rates. In the IMQ-induced psoriasis-like mouse model, Huai'er (Trametes) treatment reduced erythema, scaling, and dermal infiltration of inflammatory cells, demonstrating its efficacy in alleviating psoriasis symptoms. Network pharmacology and transcriptomic analyses identified signal transducer and activator of transcription 1 (STAT1) as a central target modulated by Huai'er (Trametes). This regulation was associated with decreased expression of pro-inflammatory cytokines, including interleukin-17A and tumor necrosis factor alpha, both in vitro and in vivo.

Conclusion: This study demonstrates that Huai'er (Trametes) exerts therapeutic effects on psoriasis by modulating STAT1, thereby inhibiting keratinocyte proliferation and inflammatory responses. The findings provide a foundation for further research into the potential of Huai'er (Trametes) as a treatment for psoriasis.

目的:探讨槐耳对银屑病的治疗作用,探讨其调节角质细胞行为和免疫反应的分子靶点和途径。方法:采用人角质形成细胞系(HaCaT)角质形成细胞进行细胞实验,观察槐儿对细胞增殖、迁移及炎症因子表达的影响。另外,建立咪喹莫特(IMQ)诱导的银屑病样小鼠模型,观察怀儿在体内的治疗效果。进行网络药理学和转录组学分析以确定潜在的靶点和途径。结果:槐儿显著抑制HaCaT角化细胞体外增殖和迁移,减少5-乙基-2'-脱氧尿苷掺入和伤口愈合率。在imq诱导的银屑病样小鼠模型中,槐儿(Trametes)治疗可减轻红斑、结垢和皮肤炎症细胞浸润,显示其缓解银屑病症状的功效。网络药理学和转录组学分析发现,信号转导因子和转录激活因子1 (STAT1)是由槐儿(Trametes)调节的中心靶点。这种调节与促炎细胞因子的表达减少有关,包括白细胞介素- 17a和肿瘤坏死因子α,在体外和体内都是如此。结论:本研究表明槐耳通过调节STAT1对银屑病有治疗作用,从而抑制角化细胞增殖和炎症反应。研究结果为进一步研究槐耳治疗银屑病的潜力奠定了基础。
{"title":"Psoriasis intervention by Huai'er (): unveiling novel targetsnetwork pharmacology.","authors":"L I Keyao, Shu Ye, Chang Jing, Tang Jianping, Zhang Litao, Wei Zhu","doi":"10.19852/j.cnki.jtcm.2025.06.011","DOIUrl":"10.19852/j.cnki.jtcm.2025.06.011","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the therapeutic effects of Huai'er (<i>Trametes</i>) on psoriasis by identifying specific molecular targets and pathways involved in regulating keratinocyte behavior and immune responses.</p><p><strong>Methods: </strong>Cellular experiments were conducted using human keratinocyte cell line (HaCaT) keratinocytes to evaluate the effects of Huai'er (<i>Trametes</i>) on cell proliferation, migration, and inflammatory factor expression. Additionally, an imiquimod (IMQ)-induced psoriasis-like mouse model was established to assess the therapeutic efficacy of Huai'er (<i>Trametes</i>) <i>in vivo</i>. Network pharmacology and transcriptomic analyses were performed to identify potential targets and pathways.</p><p><strong>Results: </strong>Huai'er (<i>Trametes</i>) significantly inhibited HaCaT keratinocyte proliferation and migration <i>in vitro</i>, as evidenced by reduced 5-ethynyl-2'-deoxyuridine incorporation and wound healing rates. In the IMQ-induced psoriasis-like mouse model, Huai'er (<i>Trametes</i>) treatment reduced erythema, scaling, and dermal infiltration of inflammatory cells, demonstrating its efficacy in alleviating psoriasis symptoms. Network pharmacology and transcriptomic analyses identified signal transducer and activator of transcription 1 (STAT1) as a central target modulated by Huai'er (<i>Trametes</i>). This regulation was associated with decreased expression of pro-inflammatory cytokines, including interleukin-17A and tumor necrosis factor alpha, both <i>in vitro</i> and <i>in vivo</i>.</p><p><strong>Conclusion: </strong>This study demonstrates that Huai'er (<i>Trametes</i>) exerts therapeutic effects on psoriasis by modulating STAT1, thereby inhibiting keratinocyte proliferation and inflammatory responses. The findings provide a foundation for further research into the potential of Huai'er (<i>Trametes</i>) as a treatment for psoriasis.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"45 6","pages":"1317-1329"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12711639/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145727921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of 4 kinds of Chinese traditional Qigong exercises on cervical spondylosis: a network Meta-analysis. 4种气功运动对颈椎病的影响:网络meta分析。
Pub Date : 2025-12-01 DOI: 10.19852/j.cnki.jtcm.2025.06.003
Wan Le, Jiang Weiyu, Zhang Wenchun, Yingsin Peng, Liu Jiancheng

Objective: To access the effectuveness of four different types of Chinese traditional Qigong exercises in the management of cervical spondylosis.

Methods: Observational studies published up to July 2024 were searched in online databases: China National Knowledge Infrastructure Database, Wanfang, China Science and Technology Journal Database, SinoMed, PubMed, Cochrane Library, Embase, and Web of Science). The quality of the included randomized controlled trial (RCT) was evaluated using the Cochrane risk-of-bias tool. A total of 623 studies were retrieved, of which 44 were considered eligible. Four kinds of Chinese traditional Qigong exercises were involved, including Tai Chi, Baduanjin, Yijinjing and Wuqinxi.

Results: In the treatment of cervical spondylosis, Baduanjin, Yijinjing, Tai Chi, Wuqinxi plus standard of care (SOC) were more effective than SOC in improving the comprehensive curative effect, reducing the index of neck disability index, visual analogue scale and Yasuhisa Tanaka Cervial Spine Assessment Questionnaire.

Conclusion: Chinese traditional Qigong exercises are recommended as a treatment option for cervical spondylosis.

目的:探讨四种不同类型气功练习对颈椎病的治疗效果。方法:检索截至2024年7月发表的观察性研究,检索数据库为:中国国家知识基础数据库、万方、中国科技期刊库、中国医学信息网、PubMed、Cochrane图书馆、Embase和Web of Science。采用Cochrane风险偏倚工具评估纳入的随机对照试验(RCT)的质量。共检索了623项研究,其中44项被认为符合条件。其中包括四种中国传统气功,包括太极拳、八段锦、易金经和五琴舞。结果:在颈椎病治疗中,八段金、益金经、太极、五芩溪加护理标准(SOC)在提高综合疗效、降低颈部残疾指数、视觉模拟量表和田中康久颈椎评估问卷等方面均优于SOC。结论:中国传统气功运动被推荐作为颈椎病的治疗选择。
{"title":"Effects of 4 kinds of Chinese traditional Qigong exercises on cervical spondylosis: a network Meta-analysis.","authors":"Wan Le, Jiang Weiyu, Zhang Wenchun, Yingsin Peng, Liu Jiancheng","doi":"10.19852/j.cnki.jtcm.2025.06.003","DOIUrl":"10.19852/j.cnki.jtcm.2025.06.003","url":null,"abstract":"<p><strong>Objective: </strong>To access the effectuveness of four different types of Chinese traditional Qigong exercises in the management of cervical spondylosis.</p><p><strong>Methods: </strong>Observational studies published up to July 2024 were searched in online databases: China National Knowledge Infrastructure Database, Wanfang, China Science and Technology Journal Database, SinoMed, PubMed, Cochrane Library, Embase, and Web of Science). The quality of the included randomized controlled trial (RCT) was evaluated using the Cochrane risk-of-bias tool. A total of 623 studies were retrieved, of which 44 were considered eligible. Four kinds of Chinese traditional Qigong exercises were involved, including Tai Chi, Baduanjin, Yijinjing and Wuqinxi.</p><p><strong>Results: </strong>In the treatment of cervical spondylosis, Baduanjin, Yijinjing, Tai Chi, Wuqinxi plus standard of care (SOC) were more effective than SOC in improving the comprehensive curative effect, reducing the index of neck disability index, visual analogue scale and Yasuhisa Tanaka Cervial Spine Assessment Questionnaire.</p><p><strong>Conclusion: </strong>Chinese traditional Qigong exercises are recommended as a treatment option for cervical spondylosis.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"45 6","pages":"1191-1200"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12711637/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145727823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Network pharmacology combined with experiments to explore the molecular mechanism of Jiawei Erzhi pill protects against atherosclerosis by inhibiting ferroptosis. 网络药理学结合实验探讨加味二脂丸抑制铁下垂对动脉粥样硬化的分子机制。
Pub Date : 2025-12-01 DOI: 10.19852/j.cnki.jtcm.2025.06.012
M A Guiping, Chen Ran, L I Junlong, Sun Le, H U Shiping, Zhang Yiyi, Hong Chuangxiong

Objective: To elucidate the possible mechanism of Jiawei Erzhi pill (, JWEZP) in the treatment of atherosclerosis (AS).

Methods: The chemical constituents of JWEZP were identified using ultra-performance liquid chromatography-mass spectrometry. A high-fat diet (HFD) was used to establish AS models in ApoE-/- mice. The ApoE-/- mice were randomly divided into the Model (normal saline), Simvastatin (normal saline), Low-dose JWEZP, Medium-dose JWEZP and High-dose JWEZP groups (n = 15), and C57BL/6 mice on a normal diet were used as the control group. Mice were treated with JWEZP at different doses (3.9, 7.8, 15.6 g·kg?1·d?1) or with simvastatin (2.6 mg·kg?1·d?1) for ten weeks. The inhibitory effects of JWEZP on AS were assessed by measuring serum lipid levels and changes in atherosclerotic plaques, lipid peroxidation and ferroptosis. Common targets and key regulatory pathways of JWEZP-mediated inhibition of ferroptosis were predicted using network pharmacology and verified using real-time quantitative polymerase chain reaction (RT-qPCR) and Western blotting.

Results: We identified 46 active compounds in JWEZP. Mice in the JWEZP group had lower body weights and serum cholesterol levels compared to HFD mice. The results of Hematoxylin-Eosin and Oil Red O staining showed that JWEZP alleviated AS. Masson staining showed that JWEZP improved the stability of atherosclerotic plaques. In addition, JWEZP-treated mice had lower levels of reactive oxygen species (ROS) in thoracic aortic tissue according to ROS fluorescence staining. The ELISA results showed that JWEZP decreased the levels of iron, lipid peroxide, malondialdehyde and nicotinamide adenine dinucleotide phosphate and increased the levels of glutathione (GSH) and GSH-PX in the thoracic aortic tissues of mice. The expression of glutathione peroxidase 4 in the thoracic aorta of mice in the JWEZP group was upregulated in the results of the immunofluorescence assay. Network pharmacology results indicated that the action mechanisms of JWEZP-mediated inhibition of ferroptosis were closely related to the p53, mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase (PI3K)/ protein kinase B (Akt) signaling pathways. RT-qPCR and Western blotting results demonstrated that JWEZP inhibited the p53 and MAPK pathways, and activated the PI3K/Akt pathway to regulate ferroptosis.

Conclusion: JWEZP improved AS by inhibiting ferroptosis. The study provides a scientific basis for further research and validation of JWEZP as a potential therapeutic for AS.

目的:探讨加味二脂丸治疗动脉粥样硬化(AS)的可能作用机制。方法:采用超高效液相色谱-质谱联用技术对JWEZP的化学成分进行鉴定。采用高脂饮食(HFD)建立ApoE-/-小鼠AS模型。将ApoE-/-小鼠随机分为模型(生理盐水)、辛伐他汀(生理盐水)、JWEZP低剂量组、JWEZP中剂量组和JWEZP高剂量组(n = 15),以正常饮食的C57BL/6小鼠为对照组。小鼠以不同剂量(3.9、7.8、15.6 g·kg、1·d?1)或与辛伐他汀(2.6 mg·kg?1·d?1)十个星期。通过测定血清脂质水平、动脉粥样硬化斑块、脂质过氧化和铁下垂的变化来评估JWEZP对AS的抑制作用。利用网络药理学预测jwezp介导的铁ptosis抑制的共同靶点和关键调控途径,并利用实时定量聚合酶链反应(RT-qPCR)和Western blotting进行验证。结果:共鉴定出46种有效成分。与HFD小鼠相比,JWEZP组小鼠的体重和血清胆固醇水平较低。苏木精-伊红染色和油红O染色结果显示,JWEZP对AS有缓解作用。Masson染色显示JWEZP改善了动脉粥样硬化斑块的稳定性。此外,根据ROS荧光染色,jwezp处理小鼠胸主动脉组织中活性氧(ROS)水平较低。ELISA结果显示,JWEZP可降低小鼠胸主动脉组织中铁、过氧化脂质、丙二醛和烟酰胺腺嘌呤二核苷酸磷酸水平,提高谷胱甘肽(GSH)和谷胱甘肽- px水平。免疫荧光检测结果显示,JWEZP组小鼠胸主动脉谷胱甘肽过氧化物酶4表达上调。网络药理学结果表明,jwezp介导的铁凋亡抑制作用机制与p53、丝裂原活化蛋白激酶(MAPK)、磷脂酰肌醇3-激酶(PI3K)/蛋白激酶B (Akt)信号通路密切相关。RT-qPCR和Western blotting结果显示,JWEZP抑制p53和MAPK通路,激活PI3K/Akt通路调控铁下垂。结论:JWEZP通过抑制铁下垂改善AS。本研究为进一步研究和验证JWEZP作为治疗as的潜在药物提供了科学依据。
{"title":"Network pharmacology combined with experiments to explore the molecular mechanism of Jiawei Erzhi pill protects against atherosclerosis by inhibiting ferroptosis.","authors":"M A Guiping, Chen Ran, L I Junlong, Sun Le, H U Shiping, Zhang Yiyi, Hong Chuangxiong","doi":"10.19852/j.cnki.jtcm.2025.06.012","DOIUrl":"10.19852/j.cnki.jtcm.2025.06.012","url":null,"abstract":"<p><strong>Objective: </strong>To elucidate the possible mechanism of Jiawei Erzhi pill (, JWEZP) in the treatment of atherosclerosis (AS).</p><p><strong>Methods: </strong>The chemical constituents of JWEZP were identified using ultra-performance liquid chromatography-mass spectrometry. A high-fat diet (HFD) was used to establish AS models in ApoE<sup>-/-</sup> mice. The ApoE<sup>-/-</sup> mice were randomly divided into the Model (normal saline), Simvastatin (normal saline), Low-dose JWEZP, Medium-dose JWEZP and High-dose JWEZP groups (<i>n =</i> 15), and C57BL/6 mice on a normal diet were used as the control group. Mice were treated with JWEZP at different doses (3.9, 7.8, 15.6 g·kg?<sup>1</sup>·d?<sup>1</sup>) or with simvastatin (2.6 mg·kg?<sup>1</sup>·d?<sup>1</sup>) for ten weeks. The inhibitory effects of JWEZP on AS were assessed by measuring serum lipid levels and changes in atherosclerotic plaques, lipid peroxidation and ferroptosis. Common targets and key regulatory pathways of JWEZP-mediated inhibition of ferroptosis were predicted using network pharmacology and verified using real-time quantitative polymerase chain reaction (RT-qPCR) and Western blotting.</p><p><strong>Results: </strong>We identified 46 active compounds in JWEZP. Mice in the JWEZP group had lower body weights and serum cholesterol levels compared to HFD mice. The results of Hematoxylin-Eosin and Oil Red O staining showed that JWEZP alleviated AS. Masson staining showed that JWEZP improved the stability of atherosclerotic plaques. In addition, JWEZP-treated mice had lower levels of reactive oxygen species (ROS) in thoracic aortic tissue according to ROS fluorescence staining. The ELISA results showed that JWEZP decreased the levels of iron, lipid peroxide, malondialdehyde and nicotinamide adenine dinucleotide phosphate and increased the levels of glutathione (GSH) and GSH-PX in the thoracic aortic tissues of mice. The expression of glutathione peroxidase 4 in the thoracic aorta of mice in the JWEZP group was upregulated in the results of the immunofluorescence assay. Network pharmacology results indicated that the action mechanisms of JWEZP-mediated inhibition of ferroptosis were closely related to the p53, mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase (PI3K)/ protein kinase B (Akt) signaling pathways. RT-qPCR and Western blotting results demonstrated that JWEZP inhibited the p53 and MAPK pathways, and activated the PI3K/Akt pathway to regulate ferroptosis.</p><p><strong>Conclusion: </strong>JWEZP improved AS by inhibiting ferroptosis. The study provides a scientific basis for further research and validation of JWEZP as a potential therapeutic for AS.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"45 6","pages":"1330-1341"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12711644/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145727843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypoglycemic mechanism of modified Gegen Qinlian decoction based on regulating the expression and DNA methylation of cholesterol transporters in the adipose tissue of type 2 diabetes mellitus rats. 葛根芩连汤加味对2型糖尿病大鼠脂肪组织胆固醇转运体表达及DNA甲基化的降血糖机制
Pub Date : 2025-12-01 DOI: 10.19852/j.cnki.jtcm.2025.06.006
Peng Shuhong, Yang Lingkun, Liu Xinyi, Zhang Mengyu, Lin Seqi, Zhang Changhua, X U Guoliang, Zhu Weifeng, Yao Pengcheng

Objective: To investigate the hypoglycemic mechanism of modified Gegen Qinlian decoction (,MGQD) by examining its regulation of cholesterol transporter expression and DNA methylation, specifically the low-density lipoprotein receptor (LDLR) and scavenger receptor class B type 1 (SR-B1), in epididymal white adipose tissue (eWAT) and inguinal white adipose tissue (iWAT) of rats with type 2 diabetes mellitus (T2DM).

Methods: The control group (CON) consisted of ten Sprague-Dawley (SD) rats fed a standard chow diet, while 80 SD rats were fed a high-fat diet and administered streptozotocin intraperitoneally to induce diabetes. The diabetic rats were randomly assigned to four groups: T2DM, metformin (MET, 200 mg/kg), low-dose MGQD (MGQDL, 5 g/kg), and high-dose MGQD (MGQDH, 10 g/kg), and received treatment via gavage for 14 weeks. Western blot (WB), quantitative real-time polymerase chain reaction (qPCR), and bisulfite sequencing PCR (BSP) were used to analyze protein levels, mRNA expression, and DNA methylation of Ldlr (gene encoding LDLR) and Srb1(gene encoding SR-B1).

Results: MGQD and metformin treatment significantly reduced blood glucose levels, restored LDLR and SR-B1 protein levels in eWAT, and effectively regulated the mRNA expression and non-cytosine-p-guanine (non-CpG) methylation of Srb1 in eWAT. A significant negative correlation was observed between the methylation of Srb1 in eWAT and its mRNA expression. However, MGQD and metformin had no significant effect on the protein levels, mRNA expression, or DNA methylation of Ldlr and Srb1 in iWAT.

Conclusions: MGQD did not significantly affect LDLR and SR-B1 expression or gene methylation in iWAT. However, its hypoglycemic effect may be linked to cholesterol regulation in eWAT. Potential mechanisms include increased LDLR protein levels, which may enhance cholesterol uptake, and increased Srb1 methylation, which may suppress its expression and consequently reduce cholesterol efflux.

目的:通过观察葛根芩连汤对2型糖尿病(T2DM)大鼠附睾白色脂肪组织(eWAT)和腹股沟白色脂肪组织(iWAT)中胆固醇转运体表达和DNA甲基化的调节作用,特别是对低密度脂蛋白受体(LDLR)和清除率受体B型1 (SR-B1)的调节作用,探讨其降血糖机制。方法:对照组(CON) 10只SD大鼠饲喂标准饲料,80只SD大鼠饲喂高脂饲料并腹腔注射链脲佐菌素诱导糖尿病。将糖尿病大鼠随机分为T2DM、二甲双胍(MET, 200 mg/kg)、低剂量MGQD (MGQDL, 5 g/kg)、高剂量MGQD (MGQDH, 10 g/kg) 4组,灌胃治疗14周。采用Western blot (WB)、定量实时聚合酶链反应(qPCR)和亚硫酸酯测序PCR (BSP)分析Ldlr(编码Ldlr的基因)和Srb1(编码SR-B1的基因)的蛋白水平、mRNA表达和DNA甲基化。结果:MGQD和二甲双胍治疗可显著降低eWAT的血糖水平,恢复eWAT中LDLR和SR-B1蛋白水平,并有效调节eWAT中Srb1 mRNA表达和非胞嘧啶-对鸟嘌呤(non-CpG)甲基化。eWAT中Srb1甲基化与其mRNA表达呈显著负相关。然而,MGQD和二甲双胍对iWAT中Ldlr和Srb1的蛋白水平、mRNA表达或DNA甲基化没有显著影响。结论:MGQD对iWAT中LDLR和SR-B1的表达及基因甲基化无显著影响。然而,它的降糖作用可能与eWAT中的胆固醇调节有关。潜在的机制包括LDLR蛋白水平的增加,这可能会增加胆固醇的摄取,以及Srb1甲基化的增加,这可能会抑制其表达,从而减少胆固醇外排。
{"title":"Hypoglycemic mechanism of modified Gegen Qinlian decoction based on regulating the expression and DNA methylation of cholesterol transporters in the adipose tissue of type 2 diabetes mellitus rats.","authors":"Peng Shuhong, Yang Lingkun, Liu Xinyi, Zhang Mengyu, Lin Seqi, Zhang Changhua, X U Guoliang, Zhu Weifeng, Yao Pengcheng","doi":"10.19852/j.cnki.jtcm.2025.06.006","DOIUrl":"10.19852/j.cnki.jtcm.2025.06.006","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the hypoglycemic mechanism of modified Gegen Qinlian decoction (,MGQD) by examining its regulation of cholesterol transporter expression and DNA methylation, specifically the low-density lipoprotein receptor (LDLR) and scavenger receptor class B type 1 (SR-B1), in epididymal white adipose tissue (eWAT) and inguinal white adipose tissue (iWAT) of rats with type 2 diabetes mellitus (T2DM).</p><p><strong>Methods: </strong>The control group (CON) consisted of ten Sprague-Dawley (SD) rats fed a standard chow diet, while 80 SD rats were fed a high-fat diet and administered streptozotocin intraperitoneally to induce diabetes. The diabetic rats were randomly assigned to four groups: T2DM, metformin (MET, 200 mg/kg), low-dose MGQD (MGQDL, 5 g/kg), and high-dose MGQD (MGQDH, 10 g/kg), and received treatment <i>via</i> gavage for 14 weeks. Western blot (WB), quantitative real-time polymerase chain reaction (qPCR), and bisulfite sequencing PCR (BSP) were used to analyze protein levels, mRNA expression, and DNA methylation of <i>Ldlr</i> (gene encoding LDLR) and <i>Srb1</i>(gene encoding SR-B1).</p><p><strong>Results: </strong>MGQD and metformin treatment significantly reduced blood glucose levels, restored LDLR and SR-B1 protein levels in eWAT, and effectively regulated the mRNA expression and non-cytosine-p-guanine (non-CpG) methylation of <i>Srb1</i> in eWAT. A significant negative correlation was observed between the methylation of <i>Srb1</i> in eWAT and its mRNA expression. However, MGQD and metformin had no significant effect on the protein levels, mRNA expression, or DNA methylation of <i>Ldlr</i> and <i>Srb1</i> in iWAT.</p><p><strong>Conclusions: </strong>MGQD did not significantly affect LDLR and SR-B1 expression or gene methylation in iWAT. However, its hypoglycemic effect may be linked to cholesterol regulation in eWAT. Potential mechanisms include increased LDLR protein levels, which may enhance cholesterol uptake, and increased <i>Srb1</i> methylation, which may suppress its expression and consequently reduce cholesterol efflux.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"45 6","pages":"1254-1262"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12711643/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145727852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New approach to overcoming antimicrobial resistance of by combining Guanghuoxiang () and Penicillin G Sodium treatments. 广藿香与青霉素G钠联合治疗耐药的新途径。
Pub Date : 2025-12-01 DOI: 10.19852/j.cnki.jtcm.2025.06.008
Jing Wenguang, Wang Zhixia, P I Wenmin, W U Haonan, L I Minghua, Wang Penglong, Cheng Xianlong, Wei Feng

Objective: Antibiotics are the main drugs used to treat bacterial infections, which have been extensively utilized across various fields. However, the problem of antimicrobial resistance (AMR) has greatly limited its use, leading to the creation of various superbugs such as Methicillin-resistant Staphylococcus aureus (MRSA), making antibiotics less effective, become a major global public health challenge. MRSA, which is resistant to most β-lactam and cephalosporin antibiotics, poses a significant threat to public health. Combination therapy has shown promise as a strategy to combat multi-drug-resistant bacteria. Chinese medicine also has potential applications in this field. Thus, we tried to find a new approach to overcoming MRSA by combining Chinese herb and penicillin G sodium (PGS).

Methods: The antibacterial activity of Guanghuoxiang (Herba Pogostemonis) samples was investigated by turbidimetry. Then using the checkerboard assay, live/ dead bacterial staining and scanning electron microscopy (SEM) to investigate whether the combination of Guanghuoxiang (Herba Pogostemonis) samples and PGS could improve the sensitivity of MRSA, and metabolomics was used to investigate the underlying mechanisms.

Results: In this study, we find that the Guanghuoxiang (Herba Pogostemonis) samples had good inhibitory effects on MRSA, and showed a synergistic effect when combined with PGS, enhancing the sensitivity of MRSA to PGS. Metabolomics data further revealed that this combination exerts a broader impact on the energy and material metabolism of the bacteria, resulting in improved antibacterial efficacy.

Conclusion: Combining Guanghuoxiang (Herba Pogostemonis) with antibiotics could improve the sensitivity of drug-resistant bacteria, provided a new direction for solving the problem of AMR, and offered a valuable strategy for clinical response to MRSA.

目的:抗生素是治疗细菌感染的主要药物,已被广泛应用于各个领域。然而,抗菌素耐药性(AMR)的问题极大地限制了其使用,导致各种超级细菌的产生,如耐甲氧西林金黄色葡萄球菌(MRSA),使抗生素的有效性降低,成为全球公共卫生的主要挑战。耐甲氧西林金黄色葡萄球菌对大多数β-内酰胺类和头孢菌素类抗生素具有耐药性,对公众健康构成重大威胁。联合治疗作为对抗多重耐药细菌的一种策略已显示出前景。中药在这一领域也有潜在的应用。因此,我们试图寻找中药与青霉素G钠(PGS)联合治疗MRSA的新途径。方法:采用浊度法测定广藿香样品的抑菌活性。然后采用棋盘法、活/死菌染色法和扫描电镜(SEM)研究广藿香(Herba Pogostemonis)样品与PGS联合使用是否能提高MRSA的敏感性,并利用代谢组学研究其作用机制。结果:本研究中,我们发现广藿香样品对MRSA具有良好的抑制作用,与PGS合用可产生协同作用,增强MRSA对PGS的敏感性。代谢组学数据进一步显示,该组合对细菌的能量和物质代谢产生更广泛的影响,从而提高了抗菌效果。结论:广藿香与抗生素联用可提高耐药菌的敏感性,为解决抗生素耐药性问题提供了新的方向,为临床应对MRSA提供了有价值的策略。
{"title":"New approach to overcoming antimicrobial resistance of by combining Guanghuoxiang () and Penicillin G Sodium treatments.","authors":"Jing Wenguang, Wang Zhixia, P I Wenmin, W U Haonan, L I Minghua, Wang Penglong, Cheng Xianlong, Wei Feng","doi":"10.19852/j.cnki.jtcm.2025.06.008","DOIUrl":"10.19852/j.cnki.jtcm.2025.06.008","url":null,"abstract":"<p><strong>Objective: </strong>Antibiotics are the main drugs used to treat bacterial infections, which have been extensively utilized across various fields. However, the problem of antimicrobial resistance (AMR) has greatly limited its use, leading to the creation of various superbugs such as Methicillin-resistant Staphylococcus aureus (MRSA), making antibiotics less effective, become a major global public health challenge. MRSA, which is resistant to most β-lactam and cephalosporin antibiotics, poses a significant threat to public health. Combination therapy has shown promise as a strategy to combat multi-drug-resistant bacteria. Chinese medicine also has potential applications in this field. Thus, we tried to find a new approach to overcoming MRSA by combining Chinese herb and penicillin G sodium (PGS).</p><p><strong>Methods: </strong>The antibacterial activity of Guanghuoxiang (<i>Herba Pogostemonis</i>) samples was investigated by turbidimetry. Then using the checkerboard assay, live/ dead bacterial staining and scanning electron microscopy (SEM) to investigate whether the combination of Guanghuoxiang (<i>Herba Pogostemonis</i>) samples and PGS could improve the sensitivity of MRSA, and metabolomics was used to investigate the underlying mechanisms.</p><p><strong>Results: </strong>In this study, we find that the Guanghuoxiang (<i>Herba Pogostemonis</i>) samples had good inhibitory effects on MRSA, and showed a synergistic effect when combined with PGS, enhancing the sensitivity of MRSA to PGS. Metabolomics data further revealed that this combination exerts a broader impact on the energy and material metabolism of the bacteria, resulting in improved antibacterial efficacy.</p><p><strong>Conclusion: </strong>Combining Guanghuoxiang (<i>Herba Pogostemonis</i>) with antibiotics could improve the sensitivity of drug-resistant bacteria, provided a new direction for solving the problem of AMR, and offered a valuable strategy for clinical response to MRSA.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"45 6","pages":"1283-1294"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12711633/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145727965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of acupuncture on brain microenvironment in rats with post-stroke limb spasticity based on single-cell transcriptome sequencing technology. 基于单细胞转录组测序技术的针刺对脑卒中后肢体痉挛大鼠脑微环境的影响
Pub Date : 2025-12-01 DOI: 10.19852/j.cnki.jtcm.20250314.001
Zhang Qiongshuai, L I Yi, Cao Fang, Zhi Mujun, Wang Le, Liu Ruyao, Feng Juanjuan

Objective: To investigate the possible mechanisms by which acupuncture improves post-stroke limb spasticity using single-cell sequencing technology.

Methods: Thirty-two rats were randomly assigned to four groups: Control, Sham, Model, and Acupuncture. The middle cerebral artery occlusion (MCAO) model was established, and the acupuncture groups received acupuncture treatment. After treatment, brain morphological changes and the degree of neurological impairment were assessed. The effect of acupuncture on the proportion of brain cell types in the ischemic penumbra of MCAO rats was analyzed using single-cell transcriptomics, and the expression and enrichment of differentially expressed genes were examined. Finally, selected differential genes were validated by Western blot and quantitative real-time polymerase chain reaction.

Results: Triphenyltetrazolium chloride staining showed that the infarct area in MCAO rats was significantly reduced after acupuncture. Garcia scoring, hematoxylin-eosin staining, Nissl staining, and terminal deoxynucleotidyl transferase dUTP nick end labeling demonstrated that acupuncture reduced brain damage. Enzyme-linked immunosorbent assay results showed that acupuncture significantly decreased serum inflammatory factors, including interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α). Single-cell transcriptome analysis revealed marked changes in cell type proportions between the Acupuncture and Model groups. A total of 207 differential genes were identified, including 157 upregulated and 50 downregulated genes. Analysis of macrophage-specific differential genes in the ischemic penumbra showed enrichment in Gene Ontology terms such as Ras protein signal transduction and regulation of GTPase activity, and Kyoto Encyclopedia of Genes and Genomes pathways including lysosome, axon guidance, and mitogen-activated protein kinase signaling. S100a8 and leukocyte specific transcript 1 (LST1) were identified as key differential genes.

Conclusion: These findings suggest that the key differential genes S100a8 and LST1 may alleviate post-stroke limb spasticity by regulating the inflammatory response in the ischemic penumbra.

目的:利用单细胞测序技术探讨针刺改善脑卒中后肢体痉挛的可能机制。方法:将32只大鼠随机分为对照组、假手术组、模型组和针刺组。建立大脑中动脉闭塞(MCAO)模型,针刺组给予针刺治疗。治疗后观察脑形态变化及神经功能损害程度。采用单细胞转录组学分析针刺对MCAO大鼠缺血半暗区脑细胞类型比例的影响,并检测差异表达基因的表达和富集情况。最后,通过Western blot和实时定量聚合酶链反应验证所选差异基因。结果:氯化三苯四唑染色显示针刺后MCAO大鼠梗死面积明显缩小。加西亚评分、苏木精-伊红染色、尼索染色和末端脱氧核苷酸转移酶dUTP缺口末端标记表明,针灸减轻了脑损伤。酶联免疫吸附试验结果显示,针刺可显著降低血清炎症因子,包括白细胞介素-1β (IL-1β)、白细胞介素-6 (IL-6)和肿瘤坏死因子-α (TNF-α)。单细胞转录组分析显示针刺组和模型组细胞类型比例有显著变化。共鉴定出207个差异基因,其中上调157个,下调50个。对缺血半暗区巨噬细胞特异性差异基因的分析显示,在Ras蛋白信号转导和GTPase活性调控等基因本体术语,以及包括溶酶体、轴突引导和丝裂原活化蛋白激酶信号传导在内的京都基因和基因组百科全书途径中,巨噬细胞特异性差异基因的富集。S100a8和白细胞特异性转录本1 (LST1)被确定为关键的差异基因。结论:提示关键差异基因S100a8和LST1可能通过调节缺血半暗区炎症反应来缓解脑卒中后肢体痉挛。
{"title":"Effect of acupuncture on brain microenvironment in rats with post-stroke limb spasticity based on single-cell transcriptome sequencing technology.","authors":"Zhang Qiongshuai, L I Yi, Cao Fang, Zhi Mujun, Wang Le, Liu Ruyao, Feng Juanjuan","doi":"10.19852/j.cnki.jtcm.20250314.001","DOIUrl":"10.19852/j.cnki.jtcm.20250314.001","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the possible mechanisms by which acupuncture improves post-stroke limb spasticity using single-cell sequencing technology.</p><p><strong>Methods: </strong>Thirty-two rats were randomly assigned to four groups: Control, Sham, Model, and Acupuncture. The middle cerebral artery occlusion (MCAO) model was established, and the acupuncture groups received acupuncture treatment. After treatment, brain morphological changes and the degree of neurological impairment were assessed. The effect of acupuncture on the proportion of brain cell types in the ischemic penumbra of MCAO rats was analyzed using single-cell transcriptomics, and the expression and enrichment of differentially expressed genes were examined. Finally, selected differential genes were validated by Western blot and quantitative real-time polymerase chain reaction.</p><p><strong>Results: </strong>Triphenyltetrazolium chloride staining showed that the infarct area in MCAO rats was significantly reduced after acupuncture. Garcia scoring, hematoxylin-eosin staining, Nissl staining, and terminal deoxynucleotidyl transferase dUTP nick end labeling demonstrated that acupuncture reduced brain damage. Enzyme-linked immunosorbent assay results showed that acupuncture significantly decreased serum inflammatory factors, including interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α). Single-cell transcriptome analysis revealed marked changes in cell type proportions between the Acupuncture and Model groups. A total of 207 differential genes were identified, including 157 upregulated and 50 downregulated genes. Analysis of macrophage-specific differential genes in the ischemic penumbra showed enrichment in Gene Ontology terms such as Ras protein signal transduction and regulation of GTPase activity, and Kyoto Encyclopedia of Genes and Genomes pathways including lysosome, axon guidance, and mitogen-activated protein kinase signaling. S100a8 and leukocyte specific transcript 1 (LST1) were identified as key differential genes.</p><p><strong>Conclusion: </strong>These findings suggest that the key differential genes S100a8 and LST1 may alleviate post-stroke limb spasticity by regulating the inflammatory response in the ischemic penumbra.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"45 6","pages":"1273-1282"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12711642/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145727797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1